Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-13-303669
Filing Date
2013-07-26
Accepted
2013-07-26 07:31:24
Documents
6
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A d573267d10qa.htm 10-Q/A 22305
2 EX-10.2 d573267dex102.htm EX-10.2 410784
3 EX-31.1 d573267dex311.htm EX-31.1 3532
4 EX-31.2 d573267dex312.htm EX-31.2 3528
5 GRAPHIC g573267ex10_2pg74a.jpg GRAPHIC 11261
6 GRAPHIC g573267ex10_2pg74b.jpg GRAPHIC 11390
  Complete submission text file 0001193125-13-303669.txt   472730
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-50743 | Film No.: 13987803
SIC: 2834 Pharmaceutical Preparations